Get started
Author

Anna Wolska

Observed names: A Wolska, A. Wolska, A. Wolska-Washer, Anna Ewa Wolska-Washer, Anna Wolska-Washer, Anna Wolska‐Washer, Anna Wolska‑Washer, Wolska-Washer, Anna
ORCID: 0000-0001-8838-2098
Observed ORCID: 0000-0001-8838-2098
OpenAlex ID: A5101518874
Safety and Tolerability of Antibody-Drug Conjugates in Cancer
2019 · Anna Wolska-Washer, Tadeusz Robak · Drug Safety · 128
PDF
Toll-like receptors and their role in carcinogenesis and anti-tumor treatment
2008 · Anna Wolska, Ewa Lech-Marańda, et al. · Cellular & Molecular Biology Letters · 77
PDF
Increased Responsiveness to Toll‐Like Receptor 4 Stimulation in Peripheral Blood Mononuclear Cells from Patients with Recent Onset Rheumatoid Arthritis
2008 · M. L. Kowalski, A. Wolska, et al. · Mediators of Inflammation · 69
PDF
Expression of Toll-Like Receptors 3, 7, and 9 in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
2014 · Agnieszka Klonowska-Szymczyk, Anna Wolska, et al. · Mediators of Inflammation · 65
PDF
Toll-Like Receptors and their Role in Hematologic Malignancies
2009 · Anna Wolska, Ewa Lech-Maranda, et al. · Current Molecular Medicine · 30
Polymorphism of CD44 Influences the Efficacy of CD34+ Cells Mobilization in Patients with Hematological Malignancies
2014 · Anna Szmigielska-Kaplon, Janusz Szemraj, et al. · Transplantation and Cellular Therapy · 29
PDF
Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity
2011 · T. Robak, A. Szmigielska-Kaplon, et al. · Current Medicinal Chemistry · 29
Glasdegib in the Treatment of Acute Myeloid Leukemia
2019 · Anna Wolska-Washer, Tadeusz Robak · Future Oncology · 27
Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients
2010 · Agnieszka Pluta, Agata Wrzesien-Kus, et al. · Leukemia Research · 26
Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults
2020 · Anna Sokołowska, Anna S. Świerzko, et al. · Scientific Reports · 24
PDF
Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions
2023 · Anna Wolska-Washer, Tadeusz Robak · Frontiers in Oncology · 22
PDF
Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies
2022 · Anna Wolska-Washer, Piotr Smolewski · Cancers · 21
PDF
Emerging antibody-drug conjugates for treating lymphoid malignancies
2017 · Anna Wolska-Washer, Pawel Robak, et al. · Expert Opinion on Emerging Drugs · 21
Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine
2012 · Anna Wolska, Barbara Cebula-Obrzut, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 17
Increased abundance of Firmicutes and depletion of Bacteroidota predicts poor outcome in chronic lymphocytic leukemia
2024 · Magdalena Paziewska, Monika Szelest, et al. · Oncology Letters · 15
PDF
The preclinical discovery and development of orelabrutinib as a novel treatment option for B-cell lymphoid malignancies
2023 · Paweł Robak, Magda Witkowska, et al. · Expert Opinion on Drug Discovery · 15
Acalabrutinib: a bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemia
2022 · Anna Wolska-Washer, Tadeusz Robak · Expert Review of Hematology · 14
Potential breakthroughs with investigational drugs for hairy cell leukemia
2015 · Tadeusz Robak, Anna Wolska, et al. · Expert Opinion on Investigational Drugs · 12
Advances in the pharmacotherapeutic options for primary nodal peripheral T-cell lymphoma
2021 · Anna Wolska-Washer, Piotr Smolewski, et al. · Expert Opinion on Pharmacotherapy · 10
BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance
2024 · Tadeusz Robak, Magdalena Witkowska, et al. · Expert Review of Hematology · 9
The kinetics and apoptotic profile of circulating endothelial cells in autologous hematopoietic stem cell transplantation in patients with lymphoproliferative disorders
2013 · Anna Szmigielska-Kaplon, Anna Krawczynska, et al. · Annals of Hematology · 8
Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult leukemia group
2025 · Klaudia Zielonka, Błażej Izdebski, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
PDF
Ciprofloxacin prophylaxis for patients undergoing high-dose chemotherapy and autologous stem cell transplantation (ASCT) – a single-center experience
2012 · A Wolska, T Robak, et al. · Advances in Medical Sciences · 6
Acalabrutinib in treatment of patients with chronic lymphocytic leukemia including those at high genetic risk
2025 · Anna Ewa Wolska-Washer, Tadeusz Robak · Acta Haematologica Polonica · 5
PDF
Metabolic and toxicological considerations for phosphoinositide 3-kinase delta inhibitors in the treatment of chronic lymphocytic leukemia
2023 · Magdalena Witkowska, Agata Majchrzak, et al. · Expert Opinion on Drug Metabolism & Toxicology · 4
Works count: 41
Citation count: 700
H-index: 15
I10-index: 19
Year
Topic
Type